Insight Inv LLC’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
AIM
FWIA
DLA
Insight Inv LLC's BMY Position: Q2 2026 in Review
Insight Inv LLC reduced its Bristol-Myers Squibb (BMY) stake by 3.7% in Q2 2026, selling an estimated $32.4K and leaving 14,711 shares worth $848K. The position accounts for 0.4% of the portfolio, ranked #57.
Insight Inv LLC first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.17M in Q2 2022. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Insight Inv LLC held 14,711 shares of Bristol-Myers Squibb worth $848K as of Q2 2026.
- Insight Inv LLC sold 565 Bristol-Myers Squibb shares in Q2 2026, an estimated $32.4K.
- Bristol-Myers Squibb made up 0.4% of Insight Inv LLC's portfolio in Q2 2026, its #57 holding.
- Insight Inv LLC first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
- Insight Inv LLC's Bristol-Myers Squibb position peaked at $2.17M in Q2 2022.
- 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Insight Inv LLC's 13F filing for Q2 2026, filed 24 Jul 2026.